Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: First results from the research on adverse drug events and reports project Academic Article uri icon

Overview

MeSH Major

  • Adverse Drug Reaction Reporting Systems
  • Antineoplastic Agents

abstract

  • Our findings demonstrate that serious ADRs may be discovered as long as 36 years after a drug receives FDA approval. This suggests a need for continued vigilance and efficient strategies for dissemination of information about ADRs associated with cancer drugs.

publication date

  • October 15, 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2003.04.537

PubMed ID

  • 14551305

Additional Document Info

start page

  • 3859

end page

  • 66

volume

  • 21

number

  • 20